Compare UK & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UK | EDVA |
|---|---|---|
| Founded | 2015 | N/A |
| Country | China | |
| Employees | N/A | N/A |
| Industry | Business Services | Beverages (Production/Distribution) |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 1.9M |
| IPO Year | 2020 | 2012 |
| Metric | UK | EDVA |
|---|---|---|
| Price | $1.95 | $0.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.9K | ★ 180.2K |
| Earning Date | 03-24-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.30 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $73,066.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $0.23 |
| 52 Week High | $5.90 | $0.32 |
| Indicator | UK | EDVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 2.92 |
| Support Level | $1.91 | N/A |
| Resistance Level | $2.27 | N/A |
| Average True Range (ATR) | 0.15 | 0.03 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 52.36 | 13.14 |
Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has two operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.
Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.